Sun Valley Research Center, Inc.

Imperial, California 92251

2 studies enrolling now · 9 studies all time

What they study most

Alzheimer Disease, Alzheimers Disease, Attention Deficit Hyperactivity Disorder, Attention Deficit/Hyperactivity Disorder, Episodic Migraine, Obsessive Compulsive Disorder

Studies at this site

• A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease — Recruiting now
• Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies — Recruiting now
• A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder. — Completed
• A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD) — Completed
• Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder — Stopped early
• Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease — Completed
• Open-label Extension for Phase 3 Clinical Trials of Simufilam — Stopped early
• Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients — Completed
• Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine — Completed